Literature DB >> 28649954

In vitro validation of coronary CT angiography for the evaluation of complex lesions.

Carlos Collet1, Yoshinobu Onuma, Maik J Grundeken, Yosuke Miyazaki, Marcio Bittercourt, Pieter Kitslaar, Sadako Motoyama, Yukio Ozaki, Taku Asano, Jolanda J Wentzel, Geert J Streekstra, Patrick W Serruys, Robbert J de Winter, R Nils Planken.   

Abstract

AIMS: The aim of this study was to assess in vitro the diagnostic accuracy of computed tomography angiography (CTA) for the evaluation of complex coronary lesions. METHODS AND
RESULTS: Five Plexiglas phantoms with three bifurcation lesions each were designed to mimic the anatomic variations and fractal phenomena of the coronary tree. In addition, luminal stenoses were scaled up with increases of 10% from 40% to 80%, corresponding to luminal areas ranging from 3.0 mm2 to 0.22 mm2. Third-generation dual-source computed tomography was used. Automated quantitative CTA analysis was performed according to the bifurcation segment model. The primary objective was to determine the diagnostic accuracy of quantitative CTA in assessing bifurcation lesions with the phantoms as a reference. The accuracy of CTA for the assessment of minimal luminal diameter was -0.07 mm (limits of agreement -0.75 to 0.61), for reference vessel diameter 0.19 mm (limits of agreement -0.25 to 0.63) and diameter stenosis 8.2% (limits of agreement -13.2 to 29.5) with no difference regarding the location within the bifurcation (i.e., proximal and distal main vessel and side branch). In stenosis with minimal luminal diameter ≥1 mm, CTA overestimated the lesion severity (bias 0.19 mm, limits of agreement -0.09 to 0.47), whereas in lesions with severe stenosis and minimal luminal diameter ≤1 mm, CTA underestimated the lesion severity (bias -0.48 mm, limits of agreement -0.55 to -0.41). CTA was able to identify the contrast-filled lumen in all degrees of lesion severity.
CONCLUSIONS: In vitro, CTA is accurate for the evaluation of bifurcation lesions. CTA was able to distinguish contrast-filled lumen even in severe obstructive lesions. These findings require further validation in the clinical setting.

Entities:  

Mesh:

Year:  2018        PMID: 28649954     DOI: 10.4244/EIJ-D-17-00326

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  3 in total

Review 1.  SYNTAX II and SYNTAX III trials: what is the take home message for surgeons?

Authors:  Rodrigo Modolo; Carlos Collet; Yoshinobu Onuma; Patrick W Serruys
Journal:  Ann Cardiothorac Surg       Date:  2018-07

2.  Safety and feasibility evaluation of planning and execution of surgical revascularisation solely based on coronary CTA and FFRCT in patients with complex coronary artery disease: study protocol of the FASTTRACK CABG study.

Authors:  Hideyuki Kawashima; Giulio Pompilio; Daniele Andreini; Antonio L Bartorelli; Saima Mushtaq; Enrico Ferrari; Francesco Maisano; Ronny R Buechel; Kaoru Tanaka; Mark La Meir; Johan De Mey; Ulrich Schneider; Torsten Doenst; Ulf Teichgräber; Gregg W Stone; Faisal Sharif; Robbert de Winter; Brian Thomsen; Charles Taylor; Campbell Rogers; Jonathon Leipsic; William Wijns; Yoshinobu Onuma; Patrick W Serruys
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

3.  Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention planner.

Authors:  Sakura Nagumo; Carlos Collet; Bjarne L Norgaard; Hiromasa Otake; Brian Ko; Bon-Kwon Koo; Jonathon Leipsic; Daniele Andreini; Ward Heggermont; Jesper M Jensen; Yu Takahashi; Abdul Ihdayhid; Zinlong Zhang; Emanuele Barbato; Michael Maeng; Takuya Mizukami; Jozef Bartunek; Adam Updegrove; Martin Penicka; Campbell Rogers; Charles Taylor; Bernard De Bruyne; Jeroen Sonck
Journal:  Clin Cardiol       Date:  2021-03-03       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.